BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 20508339)

  • 1. Prevalence of abnormal psychometric tests and critical flicker frequency after clinical recovery of overt hepatic encephalopathy.
    Sharma P; Sharma BC; Sarin SK
    Neurol India; 2010; 58(2):220-4. PubMed ID: 20508339
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Critical flicker frequency for diagnosis and assessment of recovery from minimal hepatic encephalopathy in patients with cirrhosis.
    Sharma P; Sharma BC; Sarin SK
    Hepatobiliary Pancreat Dis Int; 2010 Feb; 9(1):27-32. PubMed ID: 20133225
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuropsychological impairment in severe acute viral hepatitis is due to minimal hepatic encephalopathy.
    Sharma P; Sharma BC; Tyagi P; Kumar M; Sarin SK
    Liver Int; 2009 Feb; 29(2):260-4. PubMed ID: 18710429
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictors of nonresponse to lactulose for minimal hepatic encephalopathy in patients with cirrhosis.
    Sharma P; Sharma BC; Sarin SK
    Liver Int; 2009 Oct; 29(9):1365-71. PubMed ID: 19555401
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Critical flicker frequency: diagnostic tool for minimal hepatic encephalopathy.
    Sharma P; Sharma BC; Puri V; Sarin SK
    J Hepatol; 2007 Jul; 47(1):67-73. PubMed ID: 17459511
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Secondary prophylaxis of hepatic encephalopathy: an open-label randomized controlled trial of lactulose versus placebo.
    Sharma BC; Sharma P; Agrawal A; Sarin SK
    Gastroenterology; 2009 Sep; 137(3):885-91, 891.e1. PubMed ID: 19501587
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Secondary prophylaxis of hepatic encephalopathy in cirrhosis: an open-label, randomized controlled trial of lactulose, probiotics, and no therapy.
    Agrawal A; Sharma BC; Sharma P; Sarin SK
    Am J Gastroenterol; 2012 Jul; 107(7):1043-50. PubMed ID: 22710579
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Minimal hepatic encephalopathy in patients with extrahepatic portal vein obstruction.
    Sharma P; Sharma BC; Puri V; Sarin SK
    Am J Gastroenterol; 2008 Jun; 103(6):1406-12. PubMed ID: 18510608
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Primary prophylaxis of overt hepatic encephalopathy in patients with cirrhosis: an open labeled randomized controlled trial of lactulose versus no lactulose.
    Sharma P; Sharma BC; Agrawal A; Sarin SK
    J Gastroenterol Hepatol; 2012 Aug; 27(8):1329-35. PubMed ID: 22606978
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Natural history of minimal hepatic encephalopathy in patients with extrahepatic portal vein obstruction.
    Sharma P; Sharma BC; Puri V; Sarin SK
    Am J Gastroenterol; 2009 Apr; 104(4):885-90. PubMed ID: 19293781
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Critical flicker frequency for quantification of low-grade hepatic encephalopathy.
    Kircheis G; Wettstein M; Timmermann L; Schnitzler A; Häussinger D
    Hepatology; 2002 Feb; 35(2):357-66. PubMed ID: 11826409
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The diagnosis of subclinical hepatic encephalopathy in patients with cirrhosis using neuropsychological tests and automated electroencephalogram analysis.
    Quero JC; Hartmann IJ; Meulstee J; Hop WC; Schalm SW
    Hepatology; 1996 Sep; 24(3):556-60. PubMed ID: 8781324
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An open-label randomized controlled trial of lactulose and probiotics in the treatment of minimal hepatic encephalopathy.
    Sharma P; Sharma BC; Puri V; Sarin SK
    Eur J Gastroenterol Hepatol; 2008 Jun; 20(6):506-11. PubMed ID: 18467909
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Value of the critical flicker frequency in patients with minimal hepatic encephalopathy.
    Romero-Gómez M; Córdoba J; Jover R; del Olmo JA; Ramírez M; Rey R; de Madaria E; Montoliu C; Nuñez D; Flavia M; Compañy L; Rodrigo JM; Felipo V
    Hepatology; 2007 Apr; 45(4):879-85. PubMed ID: 17393525
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Value of critical flicker frequency and psychometric hepatic encephalopathy score in diagnosis of low-grade hepatic encephalopathy.
    Kircheis G; Hilger N; Häussinger D
    Gastroenterology; 2014 Apr; 146(4):961-9. PubMed ID: 24365582
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effects of lactulose treatment on the course of subclinical hepatic encephalopathy].
    Zeng Z; Li YY
    Zhonghua Yi Xue Za Zhi; 2003 Jul; 83(13):1126-9. PubMed ID: 12921628
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lactulose for minimal hepatic encephalopathy in patients with extrahepatic portal vein obstruction.
    Sharma P; Sharma BC
    Saudi J Gastroenterol; 2012; 18(3):168-72. PubMed ID: 22626795
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A randomized controlled trial comparing lactulose, probiotics, and L-ornithine L-aspartate in treatment of minimal hepatic encephalopathy.
    Mittal VV; Sharma BC; Sharma P; Sarin SK
    Eur J Gastroenterol Hepatol; 2011 Aug; 23(8):725-32. PubMed ID: 21646910
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Helicobacter pylori infection, plasma ammonia levels, and psychometric testing in cirrhotic patients.
    Zullo A; Rinaldi V; Meddi P; Hassan C; Winn S; Attili AF
    Am J Gastroenterol; 1999 Aug; 94(8):2214-8. PubMed ID: 10445552
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Critical flicker frequency test for diagnosing minimal hepatic encephalopathy in patients with cirrhosis.
    Özel Coşkun BD; Özen M
    Turk J Gastroenterol; 2017 May; 28(3):191-196. PubMed ID: 28316320
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.